OTC Watch

All stocks / AWHL

Aspira Women's Health Inc. AWHL

Aspira Women's Health (AWHL): financing deals mentioned in an 8-K in December 2025, a late 10-K notice in April 2026 and the latest annual figures in plain language. Each fact links to its SEC filing.

Estimated floatLate filingCostly financing OTCQXTexas, USA
Live quote on OTC Markets

Market listing

Full name
ASPIRA WOMENS HEALTH INC
Market tier
OTCQX US
Trading status
Active
Last trade
Nov 16
Source: Stockwatch, 2026-11-17

News headlines

Aspira Women's Health and Cleveland Clinic Expand Strategic Collaboration to Advance AI-Powered Diagnostics in Women's Health
2026-05-26 09:02 · News Release
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM)
2026-04-23 08:55 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Revenue
$9,216,000
Net loss
($12,780,000)
What it means

It spends more than it earns

Under strain

Customers paid it $9.2 million in the year. It lost $12.8 million. For every $1 that came in, about $2.39 went out.

The report says
Cash and cash equivalents
$1,755,000
Net cash used in operating activities
($7,029,000)
What it means

The cash could run out soon

Under strain

It had $1.8 million in the bank and used about $585,750 a month. At that pace the money lasts about 3 months unless it borrows or sells more shares.

The report says
Total assets
$5,456,000
Total liabilities
$12,388,000
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $5.5 million. Its debts and unpaid bills add up to $12.4 million. That is about $2.27 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Estimated float2026-11-13

Estimated float about 41,646,394 shares as of 2026-11-13: 46,633,744 outstanding minus 4,987,350 held by 3 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Late filing2026-04-01

Filed NT 10-K on 2026-04-01: notice that a periodic report is late.

Rule: Late-filing notice (Form NT 10-K or NT 10-Q) in the last 12 months. Source record

Costly financing2025-12-23

8-K filed 2025-12-23 mentions: equity line.

Rule: 8-K in the last 12 months mentioning convertible notes or an equity line. Source record

Shares outstanding

Source: SEC filings
2025-12-31
43.5M
2026-03-30
43.5M
2026-03-31
43.5M
2026-05-12
43.5M
2026-06-30
46.6M
2026-08-12
46.6M
2026-09-30
46.6M
2026-11-13
46.6M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-16 8-K8-K
2026-11-16 10-Q10-Q
2026-10-02 44
2026-08-14 10-Q10-Q
2026-07-17 4/A4/A
2026-07-15 33
2026-07-15 8-K8-K
2026-07-15 44
2026-07-07 8-K/A8-K/A
2026-06-22 8-K8-K
2026-06-22 D
2026-06-17 8-K8-K

Common questions about AWHL

Does AWHL file reports with the SEC?

Yes. Aspira Women's Health files with the SEC under company number 0000926617. The most recent filing we hold is a 8-K dated 2026-11-16.

Source record

How many AWHL shares are outstanding?

46,633,744 shares as of 2026-11-13, as reported to the SEC.

Source record

Has AWHL filed reports late?

Yes. In the last 12 months it filed 1 late-filing notice, most recently a NT 10-K on 2026-04-01. A notice means a report was not ready on time; check whether the report followed.

Source record

Who runs Aspira Women's Health?

Officers named in its insider filings: John Strahley (Chief Financial Officer).

Source record

Is Aspira Women's Health making money?

Customers paid it $9.2 million in the year. It lost $12.8 million. For every $1 that came in, about $2.39 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record